Scholarlink

<p>The about 4000-residue L proteins from the <i>Nairoviridae</i> are the largest known viral polymerases, lacking global structural information and promising nucleotide analog (NA) inhibitors. Here we report structures of full-length <i>Nairoviridae</i> Crimean-Congo hemorrhagic fever virus (CCHFV) L including a 3.0-Å-resolution polymerase elongation complex that elucidates mechanisms of both early and late elongation stages. Large additions and insertions are found in all three major functional regions that contain the endonuclease, RNA-dependent RNA polymerase (RdRP), and cap-binding domain of CCHFV L, extending RNA binding paths on both sides of RdRP active site and creating interaction networks critical for virus replication as suggested by CCHFV minigenome assay data. NAs with ribose-2′-modifications identical to the hepatitis C drug sofosbuvir are found to specifically and efficiently inhibit CCHFV RdRP through immediate chain termination mechanism. Using sofosbuvir-hepatitis C virus RdRP system as the reference, the potency of these NAs is further demonstrated in competition assays in the presence of corresponding NTPs.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

RNA synthesis and substrate analog inhibition in the CCHFV polymerase

  • 期刊论文

  • 发表日期：

    2026年7月22日

查看全文
  • Hengxia Jia,
  • Bo Tang,
  • Shunli Liu,
  • Xin Wen,
  • Fan Wu,
  • Xiao Hu,
  • Hu Zhou,
  • Tingting Chong,
  • Lincan Lv,
  • Qiaojie Liu,
  • Guibo Rao,
  • Mingyu Wei,
  • Xuping Jing,
  • Sheng Cao,
  • Fei Deng,
  • Zhihong Hu,
  • Bo Shu,
  • Rui Gong,
  • Jiqin Wu,
  • Manli Wang,
  • Peng Gong

摘要

The about 4000-residue L proteins from the Nairoviridae are the largest known viral polymerases, lacking global structural information and promising nucleotide analog (NA) inhibitors. Here we report structures of full-length Nairoviridae Crimean-Congo hemorrhagic fever virus (CCHFV) L including a 3.0-Å-resolution polymerase elongation complex that elucidates mechanisms of both early and late elongation stages. Large additions and insertions are found in all three major functional regions that contain the endonuclease, RNA-dependent RNA polymerase (RdRP), and cap-binding domain of CCHFV L, extending RNA binding paths on both sides of RdRP active site and creating interaction networks critical for virus replication as suggested by CCHFV minigenome assay data. NAs with ribose-2′-modifications identical to the hepatitis C drug sofosbuvir are found to specifically and efficiently inhibit CCHFV RdRP through immediate chain termination mechanism. Using sofosbuvir-hepatitis C virus RdRP system as the reference, the potency of these NAs is further demonstrated in competition assays in the presence of corresponding NTPs.